Avelox
Product Images NDC 67296-0154

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Avelox (NDC 67296-0154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Copy Of Label (6729601543)

Avelox 400 mg tablet package label showing 5 tablets. The label includes the NDC number 67296-0154-3 and indicates prescription use only. Manufacturer is Bayer Healthcare Pharmaceuticals Inc., Wayne, NJ, and the distributor is RedPharm Drug Inc., Eden Prairie, MN. The label also shows lot number 401R0R1 and expiration date 12/12.*

FDA Label Image

Structural Formula (Image1)

Chemical structure of the active ingredient in Avelox, showing its molecular components including fluorine, oxygen, nitrogen atoms, and the hydrochloride (HCl) salt form.*

FDA Label Image

Mean Steatdy-stae Plasma Concentrations (Image2)

A line graph showing plasma concentration (µg/mL) of moxifloxacin over time (hours) for Avelox 400 mg administered orally and intravenously (i.v.). Plasma concentrations peak quickly and decline over a 24-hour period, with nearly overlapping profiles for both oral and i.v. dosing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.